Profile
NEPT ZTS TAK HLN TEVA NBIX
Company Name Neptune Wellness Solutions Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Neurocrine Biosciences, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $857.05K $53.87B $45.81B $43.16B $34.47B $15.32B
Employees 0.05K 13.80K 49.28K 24.56K 37.00K 1.80K
CEO Lisa H. Gainsborg CPA Kristin C. Peck Christophe Weber Brian James McNamara Richard D. Francis Kyle W. Gano
Ratings
NEPT ZTS TAK HLN TEVA NBIX
Quant Rating Score 3 4 3 3 3 3
Quant Rating Neutral Buy Neutral Neutral Neutral Neutral
Trading
NEPT ZTS TAK HLN TEVA NBIX
Last Close $0.2 $118.8 $14.14 $9.68 $24.59 $143.56
High 52 $0.2 $178.71 $15.52 $11.41 $25.83 $154.8
Low 52 $0.2 $118.8 $12.89 $8.73 $12.82 $87.59
Price vs. 52 Week High 0 % -33.52 % -8.89 % -15.16 % -4.8 % -7.26 %
Price vs. 52 Week Low 0 % 0 % 9.7 % 10.88 % 91.81 % 63.9 %
Total Return
NEPT ZTS TAK HLN TEVA NBIX
1 Month Return 0 % -17.53 % 0.71 % 2.11 % 27.34 % 2.48 %
3 Month Return 0 % -21.96 % -6.73 % -0.05 % 36.16 % 7.83 %
6 Month Return 0 % -27.13 % 0.21 % -10.37 % 45.16 % 18.63 %
9 Month Return 0 % -24.08 % 1.73 % -3.1 % 48.4 % 25.96 %
YTD Return 0 % -27.09 % 6.8 % 1.47 % 11.57 % 5.17 %
1 Year Return 0 % -32.33 % 3.82 % 2.11 % 46.28 % 20.51 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
NEPT ZTS TAK HLN TEVA NBIX
Dividend Yield Percentage (TTM) - 1.64 % 4.41 % 1.56 % - -
Dividend Paid and Capex Coverage Ration (TTM) -30.68 % 1.89 % 2.01 % 2.01 % 2.78 % 14.57 %
Dividend Per Share (TTM) - 2 % 198 % 0.06 % - -
Payout Ratio (TTM) - 32.55 % 226.17 % 27.27 % - -
Profitability
NEPT ZTS TAK HLN TEVA NBIX
Gross Profit Margin TTM -4.7 % 70.63 % 52.77 % 61.81 % 49.6 % 98.37 %
Return on Assets TTM -195.48 % 17.49 % 0.98 % 4.78 % -0.39 % 10.03 %
Return on Equity TTM -334.26 % 53.56 % 1.95 % 9.4 % -2.58 % 15.82 %
Return on Capital Employed TTM 1017.7 % 26.48 % 4.8 % 8.34 % 3.16 % 15.17 %
Net Income Per EBT TTM 68.08 % 79.59 % 72.4 % 76.52 % 222.54 % 68.09 %
EBT Per Ebit TTM 86.34 % 94.2 % 33.29 % 88.09 % -7.94 % 114.25 %
EBIT Per Revenue TTM -195.47 % 37.63 % 12.68 % 20.49 % 5.38 % 20.51 %
Cash Flow To Debt Ratio TTM -112.87 % 1429.41 % 22.35 % 12.02 % 7.93 % 148.65 %
Receivables Turnover TTM 7.01 6.1 6.59 5.14 4.67 3.69
Payables Turnover TTM 2.68 6.73 5.02 1.18 3.35 0.37
Inventory Turnover TTM 4.24 1.12 1.71 3.72 2.4 0.63
Fixed Asset Turnover TTM 1573.14 % 241.44 % 229.02 % 589.57 % 321.73 % 473.81 %
Asset Turnover TTM 170.12 % 61.99 % 31.99 % 34.62 % 41.43 % 62.89 %
Operating Cash Flow Per Share TTM -3869.65 6.58 643.53 0.11 1.21 6.41
Free Cash Flow Per Share TTM -3995.78 5.06 521.29 0.1 0.78 5.97
Cash Per Share TTM 27239.19 % 470.54 % 22368.59 % 7.46 % 188.4 % 1121.53 %
Operating Cash Flow Sales Ratio TTM -54.29 % 31.03 % 22.48 % 9.32 % 8.36 % 23.74 %
Free Cash Flow Operating Cash Flow Ratio TTM 103.26 % 76.82 % 81.01 % 90.65 % 64.03 % 93.14 %
Cash Flow Coverage Ratios TTM -112.87 % 1429.41 % 22.35 % 12.02 % 7.93 % 148.65 %
Price To Free Cash Flows Ratio TTM - 24.05 8.68 34.34 39.1 25.82
Price To Operating Cash Flows Ratio TTM - 18.57 6.98 31.66 25.03 24.04
Price Cash Flow Ratio TTM - 18.57 6.98 31.66 25.03 24.04
Income Statement (TTM)
NEPT ZTS TAK HLN TEVA NBIX
Revenue $0.05B $9.26B $4581.55B $11.23B $16.54B $2.36B
Gross Profit $-0.02B $6.4B $3001.33B $6.95B $8.06B $2.32B
Gross Profit Ratio -41.51% 69.1% 65.51% 61.85% 48.74% 98.56%
EBITDA $-0.06B $3.87B $1210.51B $2.51B $4.43B $0.64B
Net Income $-0.08B $2.49B $107.93B $1.44B $-1.64B $0.34B
EPS Diluted -276.7 5.47 33.62 0.32 -1.45 3.29
Balance Sheet (MRQ)
NEPT ZTS TAK HLN TEVA NBIX
Long Term Debt $0.02B $5.39B $3966.33B $8.62B $16.3B $0.46B
Total Liabilities $0.06B $9.47B $7312.37B $18.09B $33.61B $1.13B
Total Equity $-0.03B $4.77B $6935.98B $16.22B $5.72B $2.59B
Total Investments $0B $0.03B $382.4B $0.14B $0B $1.71B
Total Debt $0.03B $6.74B $4515.27B $10.1B $18.08B $0.46B
Total Assets $0.03B $14.24B $14248.34B $34.32B $39.33B $3.72B
Cash Flow Statement (TTM)
NEPT ZTS TAK HLN TEVA NBIX
Net Income $2.5B $107.93B $1.44B $-1.65B $0.34B
Inventory $-0.04B $-34.97B $0.22B $0B $-0.02B
Dividends Paid $-0.79B $-302.5B $-0.57B $0B $0B
Operating Cash Flow $2.95B $1057.18B $2.3B $2.55B $0.6B
Capital Expenditure $-0.66B $-200.8B $-0.25B $-0.5B $-0.04B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 5.57
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 0.74
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 5
ALVOW Alvotech 0.66
AMPH Amphastar Pharmaceuticals, Inc. 26.07
AMRX Amneal Pharmaceuticals, Inc. 12.33
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 82.35
APUS Apimeds Pharmaceuticals US, Inc 1.96
AQST Aquestive Therapeutics, Inc. 5.63
ASRT Assertio Holdings, Inc. 0.7372
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 21.4
ETFs With Exposure to NEPT
Ticker ETF Name Weight Percentage Price
TOKE Cambria Cannabis ETF 1.63 6.88
CNBS Amplify Growth Opportunities ETF 0 40.29
Unlock